New CAR T Cells Could Help Avoid Patient Relapse in Blood Cancers (1 of 1) (VIDEO)

American Association for the Advancement of Science (AAAS)

Caption

City of Hope's Drs. Larry Kwak and Hong Qin discuss their research on BAFF-R CAR T therapy for leukemias and lymphomas. This material relates to a paper that appeared in the Sept. 25, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by H. Qin at Beckman Research Institute of City of Hope in Duarte, CA; and colleagues was titled, "CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies."

Credit

City of Hope

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.